Back

Cardiovascular burden of the amyloidogenic V1421 transthyretin variant in black individuals

12 May 2024 (08:30 - 08:38)
Organised by: Logo
Congress Presentation Part of: Late breaking science: registries Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Senthil Selvaraj

Duke University School of Medicine, Durham (United States of America)

9 More presentations in this session

Presentation thumbnail
Discussant review - Cardiovascular Burden of the V142I Variant
Doctor M. Merlo (Trieste, IT)
Slides Video
Presentation thumbnail
Incidence and prognosis of respiratory failure in acute heart failure
Doctor O. Miro (Barcelona, ES)
Slides Video
Presentation thumbnail
Discussant review - Patient oxigenation and outcome
Professor S. Price (London, GB)
Slides Video
Presentation thumbnail
Sex-specific clinical outcomes and healthcare resource utilization in the 5 years following hospitalization for heart failure
Doctor T. Averbuch (Calgary, CA)
Slides Video
Presentation thumbnail
Discussant review - PACTHF
Professor I. Pina (Philadelphia, US)
Slides Video

Access the full session

Session thumbnail
Late breaking science: registries
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Age dependency of cardiovascular outcomes with the amyloidogenic p142I transthyretin variant among black individuals
thumbnail
Congress Presentation
Late life echocardiographic effects of the amyloidogenic V142I transthyretin variant
thumbnail
Congress Session
Cardiac amyloidosis from epidemiology to treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources